I was thinking about the most recent PR where it was noted that the negotiations with BP on B-OM have matured to a point where it seems like all that is left are the final B-OM results and a signature or two. It occurred to me that IPIX would be risking credibility with the BPs that they have CDAs with by making such a statement in a PR if it was not entirely true....something I think they would try to avoid at all costs, especially when there is continuing BP interest in other indications for B, P and K as well. Is my thinking correct?